Thomsen Hauke, Chen Bowang, Figlioli Gisella, Elisei Rossella, Romei Cristina, Cipollini Monica, Cristaudo Alfonso, Bambi Franco, Hoffmann Per, Herms Stefan, Landi Stefano, Hemminki Kari, Gemignani Federica, Försti Asta
Molecular Genetic Epidemiology, C050, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.
Department of Biology, University of Pisa, Pisa, Italy.
BMC Cancer. 2016 Mar 16;16:227. doi: 10.1186/s12885-016-2264-7.
Genome-wide association studies (GWASs) have identified several single-nucleotide polymorphisms (SNPs) influencing the risk of thyroid cancer (TC). Most cancer predisposition genes identified through GWASs function in a co-dominant manner, and studies have not found evidence for recessively functioning disease loci in TC. Our study examines whether homozygosity is associated with an increased risk of TC and searches for novel recessively acting disease loci.
Data from a previously conducted GWAS were used for the estimation of the proportion of phenotypic variance explained by all common SNPs, the detection of runs of homozygosity (ROH) and the determination of inbreeding to unravel their influence on TC.
Inbreeding coefficients were significantly higher among cases than controls. Association on a SNP-by-SNP basis was controlled by using the false discovery rate at a level of q* < 0.05, with 34 SNPs representing true differences in homozygosity between cases and controls. The average size, the number and total length of ROHs per person were significantly higher in cases than in controls. A total of 16 recurrent ROHs of rather short length were identified although their association with TC risk was not significant at a genome-wide level. Several recurrent ROHs harbor genes associated with risk of TC. All of the ROHs showed significant evidence for natural selection (iHS, Fst, Fay and Wu's H).
Our results support the existence of recessive alleles in TC susceptibility. Although regions of homozygosity were rather small, it might be possible that variants within these ROHs affect TC risk and may function in a recessive manner.
全基因组关联研究(GWAS)已鉴定出多个影响甲状腺癌(TC)风险的单核苷酸多态性(SNP)。通过GWAS鉴定出的大多数癌症易感基因以共显性方式发挥作用,且研究未发现TC中隐性发挥作用的疾病位点的证据。我们的研究旨在检验纯合性是否与TC风险增加相关,并寻找新的隐性作用疾病位点。
使用先前进行的GWAS数据来估计所有常见SNP解释的表型变异比例、检测纯合性片段(ROH)以及确定近亲繁殖情况,以阐明它们对TC的影响。
病例组的近亲繁殖系数显著高于对照组。通过将错误发现率控制在q* < 0.05的水平,对逐个SNP的关联性进行了控制,有34个SNP代表病例组和对照组在纯合性方面的真实差异。病例组中每人的ROH平均大小、数量和总长度均显著高于对照组。共鉴定出16个长度较短的重复性ROH,尽管它们与TC风险在全基因组水平上的关联并不显著。几个重复性ROH包含与TC风险相关的基因。所有ROH均显示出自然选择的显著证据(iHS、Fst、Fay和Wu氏H)。
我们的结果支持TC易感性中存在隐性等位基因。尽管纯合性区域相当小,但这些ROH内的变异可能会影响TC风险,并可能以隐性方式发挥作用。